Skip to main content

Table 4 Associations between significant neoplasia and bleeding observations in patients with bleeding

From: Findings in young adults at colonoscopy from a hospital service database audit

  

Age <50

%

P-value

Age ≥50

%

P-value

All

%

P-value

  

n=

  

n=

  

n=

  

Totals

Patients with bleeding

137

  

561

  

698

  

Any bleeding

With CPL/CRC

10

7.3

0.18

101

18.0

0.03

111

15.9

0.005

With SSA/P

5

3.6

0.2

17

3.0

0.53

22

3.2

0.99

With AA

4

2.9

0.54

65

11.6

0.03

69

9.9

0.008

Totals

Patients with overt bleeding

n = 108

  

n = 240

  

n = 348

  

Overt bleeding

With CPL/CRC

8

7.4

0.17

40

16.7

0.31

48

13.8

0.34

With SSA/P

4

3.7

0.21

8

3.3

0.56

12

3.4

0.42

With AA

4

3.7

0.21

23

9.6

0.49

27

7.8

0.52

Totals

Patients with occult bleeding

n = 29

  

n = 321

  

n = 350

  

Occult bleeding

With CPL/CRC

2

6.9

0.45

61

19.0

0.03

63

18.0

0.002

With SSA/P

1

3.4

0.5

9

2.8

0.31

10

2.9

0.44

With AA

0

0.0

0.5

42

13.1

0.009

42

12.0

0.001

  1. CPL/CRC CRC precursor lesions and/or CRC, SSA/P sessile serrated polyp, AA advanced conventional adenoma (≥10 mm or high-grade dysplasia or villous histology)
  2. Significant p-values are shown in italics